Advisor OS’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$213K Buy
2,655
+184
+7% +$15.2K 0.02% 527
2025
Q4
$211K Buy
+2,471
New +$203K 0.02% 464
2024
Q3
Sell
-15,102
Closed -$1.39M 415
2024
Q2
$1.39M Sell
15,102
-216
-1% -$19.1K 0.15% 115
2024
Q1
$1.46M Buy
15,318
+1,690
+12% +$142K 0.17% 110
2023
Q4
$1.04M Sell
13,628
-472
-3% -$32.8K 0.14% 137
2023
Q3
$977K Buy
14,100
+1,574
+13% +$126K 0.15% 134
2023
Q2
$1.18M Buy
12,526
+2,755
+28% +$239K 0.19% 102
2023
Q1
$808K Buy
9,771
+284
+3% +$22.3K 0.19% 129
2022
Q4
$708K Buy
9,487
+1,666
+21% +$128K 0.19% 123
2022
Q3
$645K Sell
7,821
-1,622
-17% -$156K 0.19% 107
2022
Q2
$898K Sell
9,443
-44
-0.5% -$4.55K 0.26% 89
2022
Q1
$1.12M Sell
9,487
-3,118
-25% -$350K 0.32% 75
2021
Q4
$1.63M Buy
12,605
+570
+5% +$66.5K 0.33% 76
2021
Q3
$1.36M Sell
12,035
-30
-0.2% -$3.42K 0.3% 78
2021
Q2
$1.25M Buy
12,065
+2,393
+25% +$226K 0.26% 75
2021
Q1
$810K Buy
9,672
+1,345
+16% +$114K 0.18% 98
2020
Q4
$759K Buy
8,327
+3,373
+68% +$280K 0.2% 70
2020
Q3
$395K Buy
4,954
+1,705
+52% +$133K 0.17% 67
2020
Q2
$225K Buy
+3,249
New +$231K 0.13% 120

Other funds holding EW

Advisor OS's EW Position: Q1 2026 in Review

Advisor OS increased its Edwards Lifesciences (EW) stake by 7.4% in Q1 2026, buying an estimated $15.2K and bringing the position to 2,655 shares worth $213K. The position accounts for 0.02% of the portfolio, ranked #527.

Advisor OS first reported a position in EW in Q2 2020 and has held it in 19 quarters since. The position peaked at $1.63M in Q4 2021. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Advisor OS held 2,655 shares of Edwards Lifesciences worth $213K as of Q1 2026.
  • Advisor OS bought 184 Edwards Lifesciences shares in Q1 2026, an estimated $15.2K.
  • Edwards Lifesciences made up 0.02% of Advisor OS's portfolio in Q1 2026, its #527 holding.
  • Advisor OS first reported a position in Edwards Lifesciences in Q2 2020 and has held it in 19 quarters since.
  • Advisor OS's Edwards Lifesciences position peaked at $1.63M in Q4 2021.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Advisor OS's 13F filing for Q1 2026, filed 8 May 2026.